ARCHIVES

“Treatment INDs” Seen As Major Threat To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 34 | August 21, 1987

Download PDF Visit The Full Archive

Related Articles

Men With PSA Of 7 Or Higher More Likely To Have Biopsy

February 25, 2005

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

In Brief: Fidler Wins BMS Cancer Research Award; Thomas Cech To Head Howard Hughs Inst.

April 2, 1999

Clinton To Propose $1 Billion Increase And A New Minority Health Center For NIH.

January 21, 2000

New Agent Targets Glioma Tumor Cells Prior To Surgery

May 30, 2003

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

April 4, 1997